<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                                                                                           REVIEW ARTICLE <br />                                                                                                                               published: 09 July 2014 <br />                                                                                                                       doi: 10.3389/fnmol.2014.00064 <br />  <br />  <br />  <br /> Interaction LRRK2 kinase GTPase signaling <br /> cascades <br /> Joon Y. Boon1 , Julien Dusonchet 1 , Chelsea Trengrove1 Benjamin Wolozin1,2 * <br /> 1 <br />     Department Pharmacology Experimental Therapeutics, Boston University School Medicine, Boston, MA, USA <br /> 2 <br />     Neurology, Boston University School Medicine, Boston, MA, USA <br />  <br />  <br />  <br /> Edited by:                               LRRK2 protein interacts plethora signaling molecules, complexity <br /> Jean-Marc Taymans, KU Leuven,            LRRK2 function presents challenge understanding role LRRK2 the <br /> Belgium <br />                                          pathophysiology Parkinson&#8217;s disease (PD). Studies LRRK2 using over-expression in <br /> Reviewed by: <br /> R. Jeremy Nichols, The Parkinson&#8217;s <br />                                          transgenic mice disappointing, however, studies using invertebrate systems <br /> Institute, USA                           yielded clearer picture, clear effects LRRK2 expression, knockdown <br /> Patrick Lewis, University College        deletion <span id='am-10' about='obo:NCBITaxon_6239' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_119089 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_55879 obo:NCBITaxon_131567 obo:NCBITaxon_55885 obo:NCBITaxon_6237 obo:NCBITaxon_6236 obo:NCBITaxon_33154 obo:NCBITaxon_6231 obo:NCBITaxon_1206794 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6243 obo:NCBITaxon_6072'><span id='am-11' property="rdfs:label" content="Caenorhabditis elegans" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasExactSynonym" content="roundworm" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-15'  ></span><span id='am-16' property="oboInOwl:hasRelatedSynonym" content="Rhabditis elegans" datatype="xsd:string"></span>Caenorhabditis elegans</span> Drosophila modulation survival of <br /> London, UK                               dopaminergic neurons. Recent studies begun focus attention particular signaling <br /> *Correspondence:                         cascades target LRRK2 function. LRRK2 interacts members the <br /> Benjamin Wolozin, Department of <br /> Pharmacology Experimental <br />                                          mitogen activated protein kinase (MAPK) pathway regulate pathway action <br /> Therapeutics, Boston University          acting scaffold directs location MAPK pathway activity, strongly <br /> School Medicine, 72 East Concord      affecting MAPK pathway activity. Binding GTPases, GTPase-activating <br /> Street, R614, Boston,                    proteins GTPase exchange factors strong theme LRRK2 biology, with <br /> MA 02118-2526, USA <br /> e-mail: bwolozin@bu.edu <br />                                          LRRK2 binding rac1, cdc42, rab5, rab7L1, endoA, RGS2, ArfGAP1, ArhGEF7. <br />                                          All molecules appear feed function output LRRK2 modulates <br />                                          cytoskeletal outgrowth vesicular dynamics, including autophagy. These functions likely <br />                                          impact modulation &#945;-synuclein aggregation associated toxicity eliciting disease <br />                                          processes term PD. <br />                                           Keywords: GTPase, kinase, trafficking, cytoskeleton, actin, autophagy, cell death, dopamine <br />  <br />  <br />  <br /> INTRODUCTION                                                                    protein (RIP) kinase families. The common mutation in <br /> Parkinson&#8217;s disease (PD) common age-related motor                   LRRK2 associated PD G2019S mutation located in <br /> disorder (Hsu et al., 2010a; Ferree et al., 2012). Accumulation              kinase domain LRRK2 (Wszolek et al., 2004; Zimprich <br /> aggregated &#945;-synuclein form Lewy bodies neuropathologi-                 et al., 2004). Other common amino acid substitution include <br /> cal hallmark PD (Lees et al., 2009). Mutations leucine-rich              R1441C/G/H Roc GTPase domain Y1699C COR <br /> repeat kinase 2, LRRK2, gene common genetic determinants                 domain (Taylor et al., 2006). The pathological mutations G2019S <br /> PD, 20 different mutations identi&#65533;?ed date causing              enhances kinase activity affecting GTPase activ- <br /> late-onset, familial autosomal-dominant PD (Gasser et al., 2011;                ity LRRK2; R1441C/G/H Y1699C affect GTPase <br /> Greene, 2012). The prevalent amino acid substitution muta-                 activity LRRK2 impairing GTP hydrolysis inconsis- <br /> tion LRRK2, G2019S, 1&#8211;2% sporadic PD                    tent effects kinase activity (West et al., 2005; Greggio et al., <br /> cases; sporadic PD LRRK2-associated PD clinically                2006; Ito et al., 2007; Lewis et al., 2007; Li et al., 2007). However, <br /> and neurochemically indistinguishable (Healy et al., 2008). These               underlying mechanisms linking mutations pathology <br /> all indicate LRRK2 important role pathogenesis               remain unclear. <br /> of PD. <br />     LRRK2 large ubiquitous cytoplasmic protein consisting                  LRRK2 MODULATES SURVIVAL OF DOPAMINERGIC <br /> of 2527 amino acids multiple functional domains (Cook-                     NEURONS, AUTOPHAGY, AND NEURONAL OUTGROWTH <br /> son, 2010). LRRK2 homolog mammals, termed LRRK1;                       Studies LRRK2 using over-expression transgenic mice have <br /> LRRK1 2 expression appear complementary,                         disappointing, studies showing consistent effects <br /> LRRK2 expression peaking development decreases rapidly                   occurring over-expression wildtype mutant LRRK2 <br /> after birth, LRRK2 expression increases postnatally (Simon-               (Dawson et al., 2010). Knockout LRRK2 mouse yielded <br /> Sanchez et al., 2006). The LRRK2 protein consists kinase,                    strong phenotype kidney pointing role LRRK2 in <br /> Ras-of-complex proteins (ROCs) GTPase, C-terminal ROC                        autophagy, however, clear differences brain; sug- <br /> (COR), leucine-rich repeat, ankyrin WD40 domains (Cook-                     gests mammalian LRRK2 vivo models better job <br /> son, 2010). The catalytic domains kinase ROC                    modeling cellular function/dysfunction provid- <br /> GTPase domains. The kinase domain highest sequence                      ing general model PD (Tong et al., 2010). In contrast, <br /> homology mitogen-activated protein kinase kinase kinase                      over-expression studies using invertebrate systems yielded <br /> (MKKK)/MLKs (mixed lineage kinases) receptor-interacting                    clearer results. Orthologs LRRK2 exist Drosophila <br />  <br />  <br />  <br /> Frontiers Molecular Neuroscience                                 www.frontiersin.org                                      July 2014 | Volume 7 | Article 64 | 1 <br />  Boon et al.                                                                                                  LRRK2 regulator cellular signaling <br />  <br />  <br />  <br />  <br /> and <span id='am-70' about='obo:NCBITaxon_333870' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_41084 obo:NCBITaxon_33154 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_195229 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_41087 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_71193 obo:NCBITaxon_33392 obo:NCBITaxon_50557 obo:NCBITaxon_7041'><span id='am-71' property="oboInOwl:hasRelatedSynonym" content="Nematodes Berthold, 1827" datatype="xsd:string"></span><span id='am-72'  ></span><span id='am-73' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-74' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-75' property="rdfs:label" content="Nematodes" datatype="xsd:string"></span>Nematodes</span>, <span id='am-39' about='obo:NCBITaxon_species' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-40' property="rdfs:label" content="species" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>species</span> exhibit just form                detrimental. In general, <span id='am-91' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-92' property="rdfs:label" content="Data" datatype="xsd:string"></span><span id='am-93' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-94' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-95'  ></span>data</span> suggest loss LRRK2 <br /> of LRRK, referred lrk-1 (Marin, 2008). The invertebrate              expression detrimental. <br /> LRRK2 orthologs kinase, COR ROC domains are <br /> homologous mammalian LRRK2, lrk-1 protein appears               LRRK2 REGULATES MAP KINASE SIGNALING PATHWAYS <br /> to subsume functions LRRK1 LRRK2 (Marin,                   Incorporating research multiple different venues suggests <br /> 2008; Saha et al., 2009). Studies groups examin-              roles LRRK2 differing cellular networks. Prior studies <br /> ing effects LRRK2 expression, knockdown deletion              laboratory, subsequent studies Kahle lab- <br /> <span id='am-17' about='obo:NCBITaxon_6237' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_119089 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_55879 obo:NCBITaxon_131567 obo:NCBITaxon_55885 obo:NCBITaxon_6236 obo:NCBITaxon_33154 obo:NCBITaxon_6231 obo:NCBITaxon_1206794 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6243 obo:NCBITaxon_6072'><span id='am-18' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-20'  ></span><span id='am-21' property="rdfs:label" content="Caenorhabditis" datatype="xsd:string"></span>Caenorhabditis</span> elegans Drosophila strong effects (Liu         oratory indicate LRRK2 interacts mitogen activated <br /> et al., 2008; Wang et al., 2008; Saha et al., 2009; Samann et al., 2009;   protein kinase (MAPK) pathways (Carballo-Carbajal et al., 2010; <br /> Venderova et al., 2009; Yao et al., 2010; Yuan et al., 2011). The          Hsu et al., 2010a,b). The MAPK pathway signaling network <br /> results appear differ somewhat based system,             begins membrane signaling extends mul- <br /> effects strong cases. Studies laboratory indicate        tiple successive kinases leading ultimately phosphorylation of <br /> that expressing WT LRRK2 promotes survival dopaminergic                 transcription factors act gene expression (Yang et al., 2013). <br /> neurons response rotenone treatment, mutant LRRK2                 Receptor signaling frequently begins MAP Kinase kinase <br /> (G2019S R1441C) enhances loss dopaminergic neurons rel-              kinases (MAPKKKs, termed mixed lineage kinases, MLKs), <br /> ative WT (Saha et al., 2009). Another important aspect           enzymes act initiate signaling cascades ulti- <br /> observations, important considering studies             mately lead transcriptional regulation (Yang et al., 2013). The <br /> of LRRK2 generally, G2019S potentiates loss           MLK <span id='am-7' about='obo:NCBITaxon_family' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-8' property="rdfs:label" content="family" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>family</span> kinases activates c-jun NH2-terminal kinase <br /> neuronal processes relative WT LRRK2. Because nematodes                 (JNK) pathway phosphorylating MKK4 -7 activates <br /> lack endogenous &#945;-synuclein, recently crossed LRRK2                 p38 pathway phosphorylating MKK3 -6 (Gallo and <br /> lines line expressing &#945;-synuclein dopaminergic neurons.            Johnson, 2002; Wang et al., 2004). These stress kinase complexes <br /> Interestingly, current studies new nematode model            required scaffold proteins regulation subcellular <br /> laboratory shows WT G2019S LRRK2 potentiate                  localization. In particular MAP kinase signaling cascades, <br /> age-related loss dopaminergic neurons (and processes),         JNK-interacting proteins (JIPs) group scaffold pro- <br /> suggesting understanding interaction LRRK2                teins regulation (Kelkar et al., 2005; Whitmarsh, 2006). <br /> and &#945;-synuclein important modeling pathophysiol-                Hence, MKKs recruited multi-protein com- <br /> ogy PD. Studies Chen laboratory using different              plex scaffold proteins JIPs (Habig et al., 2013). JIP1-3 regulates <br /> C. elegans model (without incorporation &#945;-synuclein)             speci&#65533;?city localization JNK pathway JIP4 is <br /> deleterious effect WT G2019S LRRK2, studies using             speci&#65533;?c scaffolding protein p38 pathway (Verhey et al., <br /> Drosophila indicate LRRK2 potentiates degeneration reti-           2001; Kelkar et al., 2005; Whitmarsh, 2006). <br /> nal cells loss dopaminergic neurons (Liu et al., 2008; Yao              Multiple studies LRRK2 interacts MAPK <br /> et al., 2010). Thus, speci&#65533;?c results depend particular          pathway kinase domain homologous MAP- <br /> model used, clear invertebrate models sen-         KKK/MLKs RIPs (West et al., 2005; Greggio Cookson, <br /> sitive modulation LRRK2 levels, mutations LRRK2               2009; Carballo-Carbajal et al., 2010; Hsu et al., 2010a,b). However, <br /> potentiate degeneration dopaminergic neurons. While mouse               studies suggest LRRK2 strong activator <br /> models particularly sensitive LRRK2 over-expression,            pathway. Our laboratory shown LRRK2 binds <br /> knockout LRRK2 appears potentiate autophagic de&#65533;?cits              MKK6, -3, -7 HEK293FT (Gloeckner et al., 2009; Hsu <br /> the kidney, site normally exhibits strong expres-          et al., 2010a). Binding LRRK2 MKK6, -3, -7, acti- <br /> sion LRRK2. <span id='am-29' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-30' property="rdfs:label" content="This" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-32'  ></span><span id='am-33' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>This</span> provides evidence effects observed            <span id='am-76' about='obo:NCBITaxon_267112' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_267089 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_33154 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_7505 obo:NCBITaxon_6970 obo:NCBITaxon_7504 obo:NCBITaxon_33341 obo:NCBITaxon_50557 obo:NCBITaxon_6072 obo:NCBITaxon_6960'><span id='am-77' property="rdfs:label" content="Vates" datatype="xsd:string"></span><span id='am-78'  ></span><span id='am-79' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-80' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>vates</span> p38 JNK pathway, activation <br /> with invertebrate systems strong relevance mammalian           strikingly modest (Hsu et al., 2010a). Receptor activation of <br /> system.                                                                    MAPK pathway produces fold increases activ- <br />     Studies using primary rodent neurons grown culture             ities downstream kinases, over-expressing LRRK2 <br /> yielded stronger results transgenic mouse mod-               increases activities kinases downstream transcrip- <br /> els. These studies consistently indicate expression mutant         tion factors 60% (Hsu et al., 2010a). Studies from <br /> LRRK2 potentiates neurodegeneration, reduces neurite out-              Kahle laboratory showed similarly low levels kinase acti- <br /> growth (Smith et al., 2005; Chan et al., 2011; Skibinski et al., 2014).    vation LRRK2 over-expression (Carballo-Carbajal et al., <br /> Interestingly, acute expression WT LRRK2 appears bene-            2010). These studies showed LRRK2 upregulates alpha- <br /> &#65533;?cial, parallels observations studies C. elegans.        synuclein transcription parallel MEK/ERK activation. This <br /> One study, using utero electroporation LRRK2 rodent           induction transcriptional upregulation alpha-synuclein was <br /> brain observed detrimental effects G2019S LRRK2                suppressed treatment selective MAPK/ERK kinase <br /> bene&#65533;?cial effects WT LRRK2, suggesting acute expres-               inhibitor, U0126 (Carballo-Carbajal et al., 2010). Disease linked <br /> sion LRRK2 rodent brain produce clearer results            mutations increased activation additional 25&#8211;30%. <br /> than chronic over-expression, occurs transgenic mice          Similar results observed analysis JIP proteins, <br /> (Macleod et al., 2006). Taken together, results indicate        act scaffolds MAPKs, function transport of <br /> mutant LRRK2 detrimental; effects WT LRRK2              MAPKs (Hsu et al., 2010b). We shown LRRK2 <br /> clear, data suggesting WT LRRK2 bene&#65533;?cial,               binds JIP1-4 associated increased levels total <br /> and data suggesting over-expression mildly               JIP1, -3, -4, oligomeric JIP, ubiquitinated JIP. In addition, <br />  <br />  <br />  <br /> Frontiers Molecular Neuroscience                            www.frontiersin.org                                July 2014 | Volume 7 | Article 64 | 2 <br />  Boon et al.                                                                                                 LRRK2 regulator cellular signaling <br />  <br />  <br />  <br />  <br /> G2019S, R1441C I2020T (but Y1699C) mutations                  modulating neuronal development function, in&#64258;uencing <br /> LRRK2 increased binding MKK6 levels JIP4 (Hsu           dopamine signaling synaptogenesis (Parisiadou et al., 2014). <br /> et al., 2010b). The stimulation JIP oligomerization partic-       The R1441C LRRK2 mutation exhibits similar neuronal effects on <br /> ularly striking effect observed co-expression LRRK2         LRRK2 knockout mice, causing dopamine signaling impairments <br /> JIPs.                                                                    neurite retraction enhanced PKA activation. PKA also <br />     Despite relatively modest effect LRRK2 MAPK            regulates LRRK2 phosphorylating S1444 ROC domain; <br /> cascades, LRRK2 produces robust effect vivo, MAPKs          14-3-3 binds phospho-serine 1444 inhibits LRRK2 <br /> appear necessary function. Our vivo studies C.      kinase activity (<span id='am-81' about='obo:NCBITaxon_1195117' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_140066 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_35567 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_7033 obo:NCBITaxon_7524 obo:NCBITaxon_6960 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_868270 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33365 obo:NCBITaxon_33342 obo:NCBITaxon_33367 obo:NCBITaxon_50557'><span id='am-82' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-83'  ></span><span id='am-84' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-85' property="rdfs:label" content="Muda" datatype="xsd:string"></span>Muda</span> et al., 2014). Binding 14-3-3 differ- <br /> elegans showed robust protection mitochondrial stress       ent phospho-epitopes (Ser-910/935) appears stabilize LRRK2, <br /> was induced LRRK2 expression. This protection depen-              reduced binding destabilizes LRRK2 causes aggregation <br /> dent action MKK6 p38 RNAi knockdown              LRRK2 form cytoplasmic inclusions (Dzamko et al., 2010). <br /> endogenous orthologs MKK6 P38 (sek-1 pmk-1) dele-           Identi&#65533;?cation targets LRRK2 kinase activity remains unclear. <br /> tion sek-1 C. elegans abolish neuroprotection LRRK2 (Hsu        Studies identi&#65533;?ed numerous putative substrates, including <br /> et al., 2010a). The MAPK cascade appears modulate            MAPK, 4E-BP, Tau (Imai et al., 2008; Berwick Harvey, <br /> effects LRRK2 autophagy (Plowey et al., 2008). Using redox         2011; Bailey et al., 2013). <br /> proteomics, demonstrated LRRK2 regulates proteins               Although LRRK2 gained attention putative <br /> associated lysosome, including ATPVA6 (Di Domenico              role modulating dopamine function, LRRK2 exerts regu- <br /> et al., 2012). Application MAPKK (MEK) inhibitor blocked        lation immune responses. LRRK2 inhibits transcription <br /> effects LRRK2 autophagy neurite shortening (Plowey          factor NFAT, plays important roles immune function as <br /> et al., 2008). Thus, interactions LRRK2 members           in&#64258;ammatory bowel disease (Liu et al., 2011). Upon over- <br /> the MAPK pathway cause signi&#65533;?cant physiological effects despite          expression LRRK2, NFAT remains cytosolic, unable to <br /> causing modest changes phosphorylation.                          translocate nucleus, suppresses transcriptional <br />     The discordance modest effects LRRK2 acti-         activity (Liu et al., 2011). The MyD88 pathway additional <br /> vation MAPK pathway strong effects LRRK2            pathway associated role LRRK2 immune <br /> protecting dopaminergic neurons nematode, strong           function. Upon in&#64258;ammation, TLR signaling MyD88 path- <br /> effect LRRK2 JIP oligomerization demands novel model             way leads phosphorylation LRRK2, implicating LRRK2 in <br /> to explain LRRK2 function. One possibility LRRK2 acts            macrophage biology (Dzamko et al., 2012). <br /> as scaffold directs location MAPK pathway activity, <br /> without strongly affecting MAPK pathway activ-             LRRK2 REGULATES SMALL GTPases <br /> ity. Location important enzymatic action           A repeating theme LRRK2 biology interactions small <br /> activity. JIPs instance, thought function vesicular        GTPases. The ROC domain LRRK2 striking forms <br /> traf&#65533;?cking. If LRRK2 exhibited role vesicular traf&#65533;?cking,      <span id='am-34' about='obo:NCBITaxon_9605' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_9526 obo:NCBITaxon_9604 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_117570 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314146 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_314293 obo:NCBITaxon_314295 obo:NCBITaxon_376913 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_207598 obo:NCBITaxon_9443'><span id='am-35' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-36' property="rdfs:label" content="Homo" datatype="xsd:string"></span><span id='am-37'  ></span><span id='am-38' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>homo</span>- hetero- dimers LRRK2 LRRK2, respectively, <br /> then impact neuronal function directing particular        vitro (Shin et al., 2008; Hsu et al., 2010a; Kumar et al., 2010). The <br /> enzymes traf&#65533;?cked vesicles, explicitly activat-       tendency LRRK2 ROC domain dimerize appears belie a <br /> ing MAPK pathway. Such role consistent          broader biological characteristic, ability bind multi- <br /> other studies suggesting function LRRK2 regulating small        ple small GTPases. As described below, shown LRRK2 <br /> GTPases associated vesicles.                                        binds small GTPase, rac1 (Chan et al., 2011). This observation <br />                                                                          parallels studies showing LRRK2 binds func- <br /> LRRK2 REGULATES MANY OTHER SIGNALING CASCADES                            tionally dependent small GTPases, rab5, rab7L1 <br /> Recent transcriptome proteome studies emphasize diverse          endoA (Matta et al., 2012; Beilina et al., 2014). Additionally, <br /> number pathways regulated LRRK2. Studies Dawson             LRRK2 binds multiple GTP modulating proteins (described fol- <br /> group recently highlighted regulation translational functions         lowing sections). In case rac1, interactions LRRK2 <br /> by LRRK2, showing LRRK2 binds phosphorylates             appears regulate site action small GTPase, and <br /> ribosomal protein RPS15 (Martin et al., 2014). This observation          leads strong effects cytoskeleton, arfGEF7, they <br /> &#65533;?ts studies showing roles LRRK2 negative        regulate growth cone (Habig et al., 2013). <br /> mediator miR mediated translational repression (Gehrke et al.,            The interaction LRRK2 rac1 observed co- <br /> 2010). The regulatory network developed identi&#65533;?es           immunoprecipitation. LRRK2 immunoprecipitate rac1 <br /> RPS15 primary member LRRK2 regulatory network,               over-expression cell lines (HEK293FT cells), as <br /> interacting LRRK2 pathway includes ADP-ribose         endogenous human brain striatum; contrast binding to <br /> polymerase TNKS (Dusonchet et al., 2014). The Cookson group              Cdc42 weak binding RhoA apparent (Chan <br /> also recently published proteomic study LRRK2, identi-        et al., 2011). Speci&#65533;?city interaction shown selective <br /> &#65533;?ed cyclin-G associated kinase (GAK) strong binding protein         precipitation rac1, precipitation classic <br /> (Beilina et al., 2014). GAK strongest genetic risk factor   Rho GTPases &#8211; Cdc42 RhoA, study did <br /> for PD, synuclein tau (Pankratz et al., 2009; Dumitriu         &#65533;?nd evidence interaction LRRK2 cdc42 (Chan et al., <br /> et al., 2011).                                                           2011; Habig et al., 2013). The interaction LRRK2 rac1 <br />     Other studies identify LRRK2 negative regulator              occurs ROC&#8211;COR kinase domains. Co-expressing <br /> PKA signaling, acting direct interaction PKAR11B,           LRRK2 rac1 enhanced rac1 activity increasing binding <br />  <br />  <br />  <br /> Frontiers Molecular Neuroscience                          www.frontiersin.org                                 July 2014 | Volume 7 | Article 64 | 3 <br />  Boon et al.                                                                                                   LRRK2 regulator cellular signaling <br />  <br />  <br />  <br />  <br /> of rac1 p21-activated kinase, turn modulates actin              cell death pathways, presumably white blood cells are <br /> cytoskeletal dynamics. LRRK2 inactivated kinase GTPase              post-mortem tissues. The LRRK2-centered association sub- <br /> domains does activate rac1 (Chan et al., 2011). LRRK2 does              network identi&#65533;?ed known interactors, novel <br /> not increase membrane-bound rac1, signi&#65533;?cantly changes               linked pathways (Dusonchet et al., 2014). For instance, network <br /> the cellular localization rac1, causing polarization,              proteins previously associated LRRK2 are <br /> is augmented LRRK2 co-expressed con-                   present network, including DJ-1, PINK1, MKK7, JIP1 <br /> stitutively active rac1. G2019S R1441C LRRK2 mutations                  (Ho et al., 2009; Sancho et al., 2009; Carballo-Carbajal et al., 2010; <br /> decrease rac1 binding; Y1699C I2020T increase rac1              Hsu et al., 2010a,b; Ferree et al., 2012; Dusonchet et al., 2014). The <br /> binding.                                                                    network identi&#65533;?ed novel networks linked LRRK2. <br />     Rac1 known play important role actin cytoskele-             Subsequent studies validated putative roles interacting <br /> ton remodeling required maintenance neurite              proteins using knockdown studies C. elegans. <br /> morphology (Chan et al., 2011). The interaction LRRK2                   Previous work laboratory established LRRK2 <br /> and rac1 results distinct effects associated changes             expression protects dopaminergic neurons degeneration <br /> the actin cytoskeleton. Previous studies shown G2019S             induced mitochondrial toxin, rotenone. We tested the <br /> induces neurite retraction in vitro vivo studies             action putative network partners LRRK2 mediated pro- <br /> through MAPK signaling pathway pathology pre-                  tection dopaminergic neurons, identi&#65533;?ed 280 genes <br /> cedes dopaminergic neuronal death apoptosis (Liou et al., 2008;          knockdown modi&#65533;?ed effects LRRK2 dopamin- <br /> Plowey et al., 2008; Parisiadou et al., 2009; Carballo-Carbajal et al.,     ergic neurons. Genes knockdown impaired LRRK2 action <br /> 2010; Hsu et al., 2010a,b). In SH-SY5Y cells, co-expression rac1         included genes known LRRK2 network (DJ- <br /> and G2019S shown rescue neurite retraction induced                1, PINK1, MKK7, JIP1), multiple genes, <br /> G2019S. These studies suggest mutations LRRK2 lead              including HDAC6, vps34 unc51, associated <br /> to decrease activation rac1, causes disassembly            autophagy (Dusonchet et al., 2014). The connection between <br /> actin &#65533;?laments leading neurite retraction (Chan et al., 2011).           LRRK2 autophagy consistent prior stud- <br />                                                                             ies, studies suggesting role LRRK2 vesicular <br /> SYSTEMS BIOLOGY PROVIDES A COMPREHENSIVE                                    biology (Biskup et al., 2006; Plowey et al., 2008; Alegre-Abarrategui <br /> ASSESSMENT OF CELLULAR PATHWAYS INTERACTING                                 et al., 2009). <br /> WITH LRRK2                                                                      One particularly interesting proteins identi&#65533;?ed the <br /> The studies showing LRRK2 interacting varied cellular             network analysis signaling gene RGS2 (regulator G pro- <br /> proteins present challenge understanding function. LRRK2          tein signaling 2), encodes GTPase-activating protein <br /> has suggested bind different proteins, including            (GAP), statistically signi&#65533;?cant regulatory &#8220;hub&#65533;? path- <br /> moesin, tubulin, MKK3, 6 7, JIP1, 3, 4, arfGAP1, arhGEF7,           ways linking LRRK2 DJ-1, PINK1, Parkin (Dusonchet <br /> endoA, cyclin-GAK, rab5, rab7L1, 14-3-3, (Imai et al., 2008; Shin           et al., 2014). RGS2 particular prior <br /> et al., 2008; Ko et al., 2009; Sancho et al., 2009; Gehrke et al., 2010;    studies indicate strong expression dopaminergic neurons. This <br /> Hsu et al., 2010a,b; Kumar et al., 2010; Nichols et al., 2010; Chan         positioning RGS2 &#8220;hub&#65533;? multiple genes linked PD <br /> et al., 2011; Matta et al., 2012; Stafa et al., 2012; Habig et al., 2013;   suggests key role RGS2 regulator LRRK2 activity, <br /> Beilina et al., 2014). LRRK2 regulatory role wide variety        function neuronal toxicity (Dusonchet et al., 2014). RGS pro- <br /> of biological processes; as, protein translations, cytoskeletal        teins family proteins characterized GAP domain <br /> processes, vesicular dynamics, neurite extension, mitochondrial             &#8764;130 amino acids, RGS domain. Other GAP proteins <br /> function, endoplasmic reticulum function, autophagy. Broad              associated LRRK2 function, including Arf- <br /> proteomics studies point interactions multiple new pro-             GAP1 ArhGEF7 (Stafa et al., 2012; Xiong et al., 2012; Habig <br /> teins, regulation mitochondrial lysosomal            et al., 2013). Although GAPs GTPase exchange factors (GEFs) <br /> proteins (Di Domenico et al., 2012; Beilina et al., 2014). The mul-         classically considered function regulating signaling of <br /> tiple functions pathways associated LRRK2 suggest                G-protein coupled receptors, GAPs exhibit strong role <br /> complex role LRRK2 neuronal biology. We approached              regulating LRRK2 GTPase activity. Recombinant RGS2 and <br /> this question using systems biology create regulatory net-          ArhGEF7 increase GTPase activity immunopuri&#65533;?ed full- <br /> work outlines multiplicity functional interactions           length LRRK2 dose-dependent manner vitro. Recombinant <br /> LRRK2 partners.                                                    RGS2 inhibits LRRK2 kinase activity dose-dependent <br />     We employed silico approach elucidate gene reg-            manner. However, concentration RGS2 required achieve <br /> ulatory network linked LRRK2 (Dusonchet et al., 2014). This              maximal inhibition LRRK2 kinase activity, occurs tenth <br /> approach used network algorithm, termed context likelihood            concentration RGS2 required stimulate GTPase <br /> of relatedness (CLR; Faith et al., 2007). This algorithm designed        activity maximally. It increasingly clear output of <br /> to analyze state-dependent genome-wide expression data based                LRRK2 modulated particular GAP GEF bound to <br /> on degree synchrony variation transcript levels          it. All GAPs GEFs appear increase LRRK2 GTPase <br /> samples. Thus, transcripts expression varies concert          activity, RGS2 ArhGEF7 reduce LRRK2 kinase activ- <br /> LRRK2 transcripts deemed neighbors. We analyzed brain              ity, ArfGAP1 increases LRRK2 autophosphorylation (Stafa <br /> and white blood cells; use white blood cells diversi&#65533;?ed path-        et al., 2012; Habig et al., 2013; Dusonchet et al., 2014). This sug- <br /> way representation away predominance genes linked                 gests output GTPase domain determine, in <br />  <br />  <br />  <br /> Frontiers Molecular Neuroscience                             www.frontiersin.org                                July 2014 | Volume 7 | Article 64 | 4 <br />  Boon et al.                                                                                                        LRRK2 regulator cellular signaling <br />  <br />  <br />  <br />  <br /> part, particular GAP GEF associated                    CONCLUSION <br /> (Figure 1).                                                                       LRRK2 large molecule molecular interactions. Mul- <br />                                                                                   tiple studies focused kinase activity, resulting <br /> GAPs AND GEFs MODULATE CYTOSKELETAL EFFECTS OF                                    identi&#65533;?cation LRRK2 inhibitors therapeutic <br /> LRRK2                                                                             bene&#65533;?t. The function LRRK2 kinase activity remains unclear, <br /> A putative role LRRK2 regulating cytoskeletal function                     LRRK2 itself robust substrate identi&#65533;?ed to <br /> consistently appears literature. LRRK2 observed                   date. Meanwhile, LRRK2 shown interact many <br /> to regulate neurite outgrowth, tubulin microtubules, traf-                    different proteins, suggesting important function LRRK2 <br /> &#65533;?cking proteins actin (Hsu et al., 2010b; Chan et al., 2011;                  lie domains linked indirectly kinase <br /> Caesar et al., 2013; Law et al., 2014). Our studies suggest                  function. A recent study suggests important action <span id='am-96' about='obo:NCBITaxon_128483' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_216303 obo:NCBITaxon_37796 obo:NCBITaxon_1206795 obo:NCBITaxon_69555 obo:NCBITaxon_6447 obo:NCBITaxon_33317 obo:NCBITaxon_6448 obo:NCBITaxon_2759 obo:NCBITaxon_6479 obo:NCBITaxon_216293 obo:NCBITaxon_6072'><span id='am-97' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-98' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-99'  ></span><span id='am-100' property="rdfs:label" content="Phos" datatype="xsd:string"></span>phos</span>- <br /> RGS2 inhibits tendency LRRK2 (WT G2019S)                            phorylation regulation LRRK2 degradation, would <br /> reduce length complexity neuronal processes primary                     imply look kinase function understand <br /> neurons (Figure 1; Dusonchet et al., 2014). Co-expression                      role LRRK2 neuron (Skibinski et al., 2014). The need <br /> RGS2 LRRK2 signi&#65533;?cantly protects G2019S LRRK2-                       look kinase function emphasized examination of <br /> induced neurite shortening, RGS2 effect                     actions GAPs GEFs LRRK2, proteins that <br /> on axonal length. ArhGEF7 increases LRRK2 GTPase activity                    exhibit seemingly similar actions LRRK2 kinase activity <br /> but induces LRRK2 increase neuronal arborization, length                   elicit opposite actions regulation neurite outgrowth and <br /> growth cone formation (Figure 1; Habig et al., 2013). In contrast,                cytoskeletal function (Figure 1). <br /> knockdown ArfGAP1 protects G2019S LRRK2-induced                            Studies laboratory laboratories iden- <br /> neurite shortening (Figure 1; Stafa et al., 2012). ArhGEF7 acts                   ti&#65533;?ed numerous signaling molecules interact with <br /> through actin cytoskeleton, raises possibility                 LRRK2. The interactions LRRK2 clearly pleiotropic, and <br /> it act tandem rac1 cdc42,                         vary depending cell type function investi- <br /> bind LRRK2 (Chan et al., 2011; Habig et al., 2013). These data                    gated. Despite complexity, distinct themes evolving, <br /> suggest small GTPases regulatory proteins act                   themes potentially important implications our <br /> regulate actions LRRK2 cytoskeleton neurite                     understanding pathophysiology PD. One theme that <br /> outgrowth (Figure 1). Redundant actions RGS2 ArhGEF7                       arises role LRRK2 regulating signaling cascades, such <br /> toward neurite cytoskeletal activity unlikely, raises                 MAPK cascade. It clear LRRK2 acts manner that <br /> the possibility RGS2 ArhGEF7 exhibit divergent effects                   different classic modulators MAPK cascade, because <br /> on LRRK2 examining functions, vesicular                        does directly stimulate phosphorylation MAP Kinases. <br /> biology.                                                                          The large size LRRK2 enables bind multiple different pro- <br />                                                                                   teins, potentially bring signaling scaffold, <br />                                                                                   analogous JIPs. <br />                                                                                       A general theme occurring &#65533;?eld PD regu- <br />                                                                                   lation vesicular transport. The vast majority genes associated <br />                                                                                   PD function related membranes vesicles. <br />                                                                                   &#945;-Synuclein thought regulate production small vesi- <br />                                                                                   cles promoting membrane curvature (Perlmutter et al., 2009; <br />                                                                                   Varkey et al., 2010; Ducas Rhoades, 2012). LRRK2 shows <br />                                                                                   strong interactions membranes thought modu- <br />                                                                                   late autophagy, involves vesicular dynamics. PINK1, <br />                                                                                   parkin, HTRA2 proteins regulate mitochondrial <br />                                                                                   function, possibly including mitophagy (Plun-Favreau et al., 2007; <br />                                                                                   Narendra et al., 2010). ATP13A2 GBA associated with <br />                                                                                   lysosomes (Mazzulli et al., 2011; Usenovic et al., 2012). The consis- <br />                                                                                   tent appearance vesicular biology pathophysiology PD <br />                                                                                   suggests interactions LRRK2 vesicles likely con- <br />                                                                                   tribute mechanism disease pathogenesis. Future studies <br />                                                                                   need speci&#65533;?cally investigate signaling pathways regu- <br />                                                                                   late interactions LRRK2 membranous organelles, such <br />                                                                                   autophagosomes. In context, preliminary data show- <br />   FIGURE 1 | Regulation LRRK2 output GTPase activity, GAPs              ing roles MAPK cascade regulating interactions of <br />   GEFs. RGS2 ArhGEF7 bind LRRK2 inhibit GTPase activity, <br />                                                                                   LRRK2 autophagic intriguing (Plowey et al., <br />   inhibits LRRK2 kinase activity appears direct LRRK2 <br />   increasing neuronal cytoskeletal activity. Rac1 small GTPase        2008). <br />   known regulate actin polymerase. Rac1 binds LRRK2 act            The complexity LRRK2 signaling provide insight the <br />   concert LRRK2 increase cytoskeletal activity. In contrast, binding   nature pathology associated LRRK2-mediated disease. <br />   ArfGAP1 LRRK2 increases autophosphorylation, appears to <br />   inhibit cytoskeletal activity. <br />                                                                                   Most cases LRRK2 mutations exhibit &#945;-synuclein pathol- <br />                                                                                   ogy, Lewy bodies, cases exhibit tau pathology <br />  <br />  <br />  <br /> Frontiers Molecular Neuroscience                                     www.frontiersin.org                             July 2014 | Volume 7 | Article 64 | 5 <br />  Boon et al.                                                                                                                                 LRRK2 regulator cellular signaling <br />  <br />  <br />  <br />  <br /> (Devine Lewis, 2008). This pathological heterogeneity                                    expression levels toxicity Parkinson&#8217;s disease: results GenePD <br /> derive impact different disease processes LRRK2                                     Study. Hum. Mol. Genet. 20, 1478&#8211;1487. doi: 10.1093/hmg/ddr026 <br />                                                                                                 Dusonchet, J., Li, H., Guillily, M., Liu, M., Stafa, K., Derada, C., et al. (2014). A <br /> biology, signaling cascades (such MAPKs) promot- <br />                                                                                                    Parkinson&#8217;s disease gene regulatory network identi&#65533;?es signaling protein RGS2 <br /> ing tau pathology signaling cascades (such vesicular                                  modulator LRRK2 activity neuronal toxicity. Hum. Mol. Genet. doi: <br /> biology) promoting &#945;-synuclein pathology.                                                          10.1093/hmg/ddu202 [Epub ahead print]. <br />                                                                                                 Dzamko, N., Deak, M., Hentati, F., Reith, A. D., Prescott, A. R., Alessi, D. <br /> AUTHOR CONTRIBUTIONS                                                                               R., et al. (2010). Inhibition LRRK2 kinase activity leads dephosphoryla- <br />                                                                                                    tion Ser(910)/Ser(935), disruption 14-3-3 binding altered cytoplasmic <br /> Joon Y. Boon drafted manuscript, Chelsea Trengrove                                             localization. Biochem. J. 430, 405&#8211;413. doi: 10.1042/BJ20100784 <br /> helped revisions, Benjamin Wolozin edited                                          Dzamko, N., Inesta-Vaquera, F., Zhang, J., Xie, C., Cai, H., Arthur, S., et al. (2012). <br /> manuscript. Julien Dusonchet provided important concepts                                       The IkappaB kinase family phosphorylates Parkinson&#8217;s disease kinase LRRK2 <br /> the manuscript.                                                                                    Ser935 Ser910 Toll-like receptor signaling. PLoS ONE 7:e39132. <br />                                                                                                    doi: 10.1371/journal.pone.0039132 <br />                                                                                                 Faith, J. J., Hayete, B., Thaden, J. T., Mogno, I., Wierzbowski, J., Cottarel, G., <br /> ACKNOWLEDGMENTS                                                                                    et al. (2007). Large-scale mapping validation <span id='am-47' about='obo:NCBITaxon_562' typeof='owl:Thing obo:NCBITaxon_561 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_91347 obo:NCBITaxon_1224 obo:NCBITaxon_2 obo:NCBITaxon_543 obo:NCBITaxon_1236'><span id='am-48' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasRelatedSynonym" content="bacterium E3" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:hasRelatedSynonym" content="Bacillus coli" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasRelatedSynonym" content="Eschericia coli" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasAlternativeId" content="NCBITaxon:662104" datatype="xsd:string"></span><span id='am-54' property="rdfs:label" content="Escherichia coli" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasRelatedSynonym" content="Bacterium coli commune" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasAlternativeId" content="NCBITaxon:662101" datatype="xsd:string"></span><span id='am-57' property="oboInOwl:hasRelatedSynonym" content="Enterococcus coli" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:hasExactSynonym" content="Escherichia/Shigella coli" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasDbXref" content="PMID:10319482" datatype="xsd:string"></span><span id='am-60'  ></span><span id='am-61' property="oboInOwl:hasRelatedSynonym" content="Escherchia coli" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasRelatedSynonym" content="Bacterium coli" datatype="xsd:string"></span>Escherichia coli</span> transcrip- <br /> This work supported grant award Benjamin Wolozin                                         tional regulation compendium expression pro&#65533;?les. PLoS Biol. 5:e8. doi: <br /> (NIH grants ES020395, NS066108, NS073679, NS060872,                                            10.1371/journal.pbio.0050008 <br /> BrightFocus Foundation, CurePSP Foundation                                          Ferree, A., Guillily, M., Li, H., Smith, K., Takashima, A., Squillace, R., et al. (2012). <br />                                                                                                    Regulation physiologic actions LRRK2: focus autophagy. Neurodegener. <br /> Alzheimer Association). <br />                                                                                                    Dis. 10, 238&#8211;241. doi: 10.1159/000332599 <br />                                                                                                 Gallo, K. A., Johnson, G. L. (2002). Mixed-lineage kinase control JNK and <br /> REFERENCES                                                                                         p38 MAPK pathways. Nat. Rev. Mol. Cell Biol. 3, 663&#8211;672. doi: 10.1038/nrm906 <br /> Alegre-Abarrategui, J., Christian, H., Lu&#65533;?no, M. M., Mutihac, R., Venda, L. L.,                 Gasser, T., Hardy, J., Mizuno, Y. (2011). Milestones PD genetics. Mov. Disord. <br />   Ansorge, O., et al. (2009). LRRK2 regulates autophagic activity localizes                 26, 1042&#8211;1048. doi: 10.1002/mds.23637 <br />   speci&#65533;?c membrane microdomains novel human genomic reporter cellular                      Gehrke, S., Imai, Y., Sokol, N., Lu, B. (2010). Pathogenic LRRK2 negatively <br />   model. Hum. Mol. Genet. 18, 4022&#8211;4034. doi: 10.1093/hmg/ddp346                                   regulates microRNA-mediated translational repression. Nature 466, 637&#8211;641. <br /> Bailey, R. M., Covy, J. P., Melrose, H. L., Rousseau, L., Watkinson, R., Knight, J., et al.        doi: 10.1038/nature09191 <br />   (2013). LRRK2 phosphorylates novel tau epitopes promotes tauopathy. Acta                  Gloeckner, C. J., Schumacher, A., Boldt, K., Uef&#65533;?ng, M. (2009). The Parkinson <br />   Neuropathol. 126, 809&#8211;827. doi: 10.1007/s00401-013-1188-4                                        disease-associated protein kinase LRRK2 exhibits MAPKKK activity phos- <br /> Beilina, A., Rudenko, I. N., Kaganovich, A., Civiero, L., Chau, H., Kalia, S. K., et al.           phorylates MKK3/6 MKK4/7, vitro. J. Neurochem. 109, 959&#8211;968. doi: <br />   (2014). Unbiased screen interactors leucine-rich repeat kinase 2 supports               10.1111/j.1471-4159.2009.06024.x <br />   common pathway sporadic familial Parkinson disease. Proc. Natl. Acad.                 Greene, J. G. (2012). Current status future directions gene expression pro&#65533;?ling <br />   Sci. U.S.A. 111, 2626&#8211;2631. doi: 10.1073/pnas.1318306111                                         Parkinson&#8217;s disease. Neurobiol. Dis. 45 76&#8211;82. doi: 10.1016/j.nbd.2010.10.022 <br /> Berwick, D. C., Harvey, K. (2011). LRRK2 signaling pathways:                            Greggio, E., Cookson, M. R. (2009). Leucine-rich repeat kinase 2 muta- <br />   key unlocking neurodegeneration? Trends Cell Biol. 21, 257&#8211;265. doi:                          tions Parkinson&#8217;s disease: questions. ASN Neuro 1:e00002. doi: <br />   10.1016/j.tcb.2011.01.001                                                                        10.1042/AN20090007 <br /> Biskup, S., Moore, D. J., Celsi, F., Higashi, S., West, A. B., Andrabi, S. A., et al. (2006).   Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, <br />   Localization LRRK2 membranous vesicular structures mammalian                        A., et al. (2006). Kinase activity required toxic effects mutant <br />   brain. Ann. Neurol. 60, 557&#8211;569. doi: 10.1002/ana.21019                                          LRRK2/dardarin. Neurobiol. Dis. 23, 329&#8211;341. doi: 10.1016/j.nbd.2006. <br /> Caesar, M., Zach, S., Carlson, C. B., Brockmann, K., Gasser, T., Gillardon, F.                 04.001 <br />   (2013). Leucine-rich repeat kinase 2 functionally interacts microtubules             Habig, K., Gellhaar, S., Heim, B., Djuric, V., Giesert, F., Wurst, W., et al. (2013). <br />   kinase-dependently modulates cell migration. Neurobiol. Dis. 54, 280&#8211;288. doi:                   LRRK2 guides actin cytoskeleton growth cones ARHGEF7 and <br />   10.1016/j.nbd.2012.12.019                                                                        Tropomyosin 4. Biochim. Biophys. Acta 1832, 2352&#8211;2367. doi: 10.1016/j.bbadis. <br /> Carballo-Carbajal, I., Weber-Endress, S., Rovelli, G., Chan, D., Wolozin, B., Klein, C.            2013.09.009 <br />   L., et al. (2010). Leucine-rich repeat kinase 2 induces alpha-synuclein expression            Healy, D. G., Falchi, M., O&#8217;Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., et al. <br />   extracellular signal-regulated kinase pathway. Cell Signal. 22, 821&#8211;827.                 (2008). International, Phenotype, genotype, worldwide genetic penetrance <br />   doi: 10.1016/j.cellsig.2010.01.006                                                               LRRK2-associated Parkinson&#8217;s disease: case-control study. Lancet Neurol. 7, <br /> Chan, D., Citro, A., Cordy, J. M., Shen, G. C., Wolozin, B. (2011). Rac1 protein               583&#8211;590. doi: 10.1016/S1474-4422(08)70117-0 <br />   rescues neurite retraction caused G2019S leucine-rich repeat kinase 2 (LRRK2).             Ho, C. C., Rideout, H. J., Ribe, E., Troy, C. M., Dauer, W. T. (2009). The <br />   J. Biol. Chem. 286, 16140&#8211;16149. doi: 10.1074/jbc.M111.234005                                    Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals <br /> Cookson, M. R. (2010). The role leucine-rich repeat kinase2 (LRRK2)                          Fas-associated protein death domain caspase-8 cellular model of <br />   Parkinson&#8217;s disease. Nat. Rev. Neurosci. 11, 791&#8211;797. doi: 10.1038/nrn2935                       neurodegeneration. J. Neurosci. 29, 1011&#8211;1016. doi: 10.1523/JNEUROSCI.5175- <br /> Dawson, T. M., Ko, H. S., Dawson, V. L. (2010). Genetic animal mod-                            08.2009 <br />   els Parkinson&#8217;s disease. Neuron 66, 646&#8211;661. doi: 10.1016/j.neuron.2010.                   Hsu, C. H., Chan, D., Greggio, E., Saha, S., Guillily, M. D., Ferree, A., et al. <br />   04.034                                                                                           (2010a). MKK6 binds regulates expression Parkinson&#8217;s disease-related <br /> Devine, M. J., Lewis, P. A. (2008). Emerging pathways genetic Parkin-                       protein LRRK2. J. Neurochem. 112, 1593&#8211;604. doi: 10.1111/j.1471-4159.2010. <br />   son&#8217;s disease: tangles, Lewy bodies LRRK2. FEBS J. 275, 5748&#8211;5757. doi:                      06568.x <br />   10.1111/j.1742-4658.2008.06707.x                                                              Hsu, C. H., Chan, D., Wolozin, B. (2010b). LRRK2 stress response: <br /> Di Domenico, F., Sultana, R., Ferree, A., Smith, K., Barone, E., Perluigi, M., et al.              interaction MKKs JNK-interacting proteins. Neurodegener. Dis. 7, 68&#8211; <br />   (2012). Redox proteomics analyses in&#64258;uence co-expression wild-                      75. doi: 10.1159/000285509 <br />   type mutated LRRK2 tau C. elegans protein expression oxidative                  Imai, Y., Gehrke, S., Wang, H. Q., Takahashi, R., Hasegawa, K., Oota, E., et al. (2008). <br />   modi&#65533;?cation: relevance Parkinson disease. Antioxid. Redox Signal. 17, 1490&#8211;                   Phosphorylation 4E-BP LRRK2 affects maintenance dopamin- <br />   1506. doi: 10.1089/ars.2011.4312                                                                 ergic neurons Drosophila. EMBO J. 27, 2432&#8211;2443. doi: 10.1038/emboj. <br /> Ducas, V. C., Rhoades, E. (2012). Quantifying interactions <span id='am-1' about='obo:NCBITaxon_3554' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_3563 obo:NCBITaxon_91827 obo:NCBITaxon_71240 obo:NCBITaxon_131221 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_3524 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_3193'><span id='am-2' property="rdfs:label" content="Beta" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasRelatedSynonym" content="Beta L. 1753" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-5'  ></span><span id='am-6' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>beta</span>-synuclein                   2008.163 <br />   gamma-synuclein model membranes. J. Mol. Biol. 423, 528&#8211;539. doi:                    Ito, G., Okai, T., Fujino, G., Takeda, K., Ichijo, H., Katada, T., et al. (2007). GTP bind- <br />   10.1016/j.jmb.2012.08.008                                                                        ing essential protein kinase activity LRRK2, causative gene product <br /> Dumitriu, A., Pacheco, C. D., Wilk, J. B., Strathearn, K. E., Latourelle, J. C., Gold-             familial Parkinson&#8217;s disease. Biochemistry 46, 1380&#8211;1388. doi: 10.1021/ <br />   wurm, S., et al. (2011). Cyclin-G-associated kinase modi&#65533;?es alpha-synuclein                      bi061960m <br />  <br />  <br />  <br /> Frontiers Molecular Neuroscience                                               www.frontiersin.org                                             July 2014 | Volume 7 | Article 64 | 6 <br />  Boon et al.                                                                                                                           LRRK2 regulator cellular signaling <br />  <br />  <br />  <br />  <br /> Kelkar, N., Standen, C. L., Davis, R. J. (2005). Role JIP4 scaffold protein   Parisiadou, L., Xie, C., Cho, H. J., Lin, X., Gu, X. L., Long, C. X., et al. (2009). <br />    regulation mitogen-activated protein kinase signaling pathways. Mol. Cell.          Phosphorylation ezrin/radixin/moesin proteins LRRK2 promotes rear- <br />    Biol. 25, 2733&#8211;2743. doi: 10.1128/MCB.25.7.2733-2743.2005                                  rangement actin cytoskeleton neuronal morphogenesis. J. Neurosci. 29, <br /> Ko, H. S., Bailey, R., Smith, W. W., Liu, Z., Shin, J. H., Lee, Y. I., et al. (2009).         13971&#8211;13980. doi: 10.1523/JNEUROSCI.3799-09.2009 <br />    CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation,             Parisiadou, L., Yu, J., Sgobio, C., Xie, C., Liu, G., Sun, L., et al. (2014). <br />    toxicity. Proc. Natl. Acad. Sci. U.S.A. 106, 2897&#8211;2902. doi: 10.1073/pnas.0810             LRRK2 regulates synaptogenesis dopamine receptor activation through <br />    123106                                                                                     modulation PKA activity. Nat. Neurosci. 17, 367&#8211;376. doi: 10.1038/ <br /> Kumar, A., Greggio, E., Beilina, A., Kaganovich, A., Chan, D., Taymans, J. M., et al.         nn.3636 <br />    (2010). The Parkinson&#8217;s disease associated LRRK2 exhibits weaker vitro phos-          Perlmutter, J. D., Braun, A. R., Sachs, J. N. (2009). Curvature dynamics <br />    phorylation 4E-BP compared autophosphorylation. PLoS ONE 5:e8730. doi:               alpha-synuclein familial Parkinson disease mutants: molecular simulations <br />    10.1371/journal.pone.0008730                                                               micelle- bilayer-bound forms. J. Biol. Chem. 284, 7177&#8211;7189. doi: <br /> Law, B. M., Spain, V. A., Leinster, V. H., Chia, R., Beilina, A., Cho, H. J., et al.          10.1074/jbc.M808895200 <br />    (2014). A direct interaction leucine-rich repeat kinase 2 speci&#65533;?c            Plowey, E. D., Cherra, S. J. III, Liu, Y. J., Chu, C. T. (2008). Role of <br />    beta-tubulin isoforms regulates tubulin acetylation. J. Biol. Chem. 289, 895&#8211;908.          autophagy G2019S-LRRK2-associated neurite shortening differentiated <br />    doi: 10.1074/jbc.M113.507913                                                               SH-SY5Y cells. J. Neurochem. 105, 1048&#8211;1056. doi: 10.1111/j.1471-4159.2008. <br /> Lees, A. J., Hardy, J., Revesz, T. (2009). Parkinson&#8217;s disease. Lancet 373, 2055&#8211;         05217.x <br />    2066. doi: 10.1016/S0140-6736(09)60492-X                                                 Plun-Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., <br /> Lewis, P. A., Greggio, E., Beilina, A., Jain, S., Baker, A., Cookson,                     et al. (2007). The mitochondrial protease HtrA2 regulated Parkinson&#8217;s <br />    M. R. (2007). The R1441C mutation LRRK2 disrupts GTP hydrolysis.                        disease-associated kinase PINK1. Nat. Cell Biol. 9, 1243&#8211;1252. doi: 10.1038/ <br />    Biochem. Biophys. Res. Commun. 357, 668&#8211;671. doi: 10.1016/j.bbrc.2007.                     ncb1644 <br />    04.006                                                                                   Saha, S., Guillily, M. D., Ferree, A., Lanceta, J., Chan, D., Ghosh, J., et al. (2009). <br /> Li, X., Tan, Y. C., Poulose, S., Olanow, C. W., Huang, X. Y., Yue, Z. (2007).             LRRK2 modulates vulnerability mitochondrial dysfunction Caenorhab- <br />    Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity               ditis elegans. J. Neurosci. 29, 9210&#8211;9218. doi: 10.1523/JNEUROSCI.2281- <br />    altered familial Parkinson&#8217;s disease R1441C/G mutants. J. Neurochem. 103,               09.2009 <br />    238&#8211;247.                                                                                 Samann, J., Hegermann, J., von Gromoff, E., Eimer, S., Baumeister, R., Schmidt, <br /> Liou, A. K., Leak, R. K., Li, L., Zigmond, M. J. (2008). Wild-type LRRK2              E. (2009). Caenorhabditits elegans LRK-1 PINK-1 act antagonistically in <br />    mutant attenuates stress-induced cell death ERK pathway. Neurobiol.            stress response neurite outgrowth. J. Biol. Chem. 284, 16482&#8211;16491. doi: <br />    Dis. 32, 116&#8211;124. doi: 10.1016/j.nbd.2008.06.016                                           10.1074/jbc.M808255200 <br /> Liu, Z., Lee, J., Krummey, S., Lu, W., Cai, H., Lenardo, M. J. (2011). The              Sancho, R. M., Law, B. M., Harvey, K. (2009). Mutations LRRK2 Roc- <br />    kinase LRRK2 regulator transcription factor NFAT modulates                COR tandem domain link Parkinson&#8217;s disease Wnt signalling pathways. Hum. <br />    severity in&#64258;ammatory bowel disease. Nat. Immunol. 12, 1063&#8211;1070. doi:               Mol. Genet. 18, 3955&#8211;3968. doi: 10.1093/hmg/ddp337 <br />    10.1038/ni.2113                                                                          Shin, N., Jeong, H., Kwon, J., Heo, H. Y., Kwon, J. J., Yun, H. J., et al. (2008). <br /> Liu, Z., Wang, X., Yu, Y., Li, X., Wang, T., Jiang, H., et al. (2008). A Drosophila model     LRRK2 regulates synaptic vesicle endocytosis. Exp. Cell Res. 314, 2055&#8211;2065. doi: <br />    LRRK2-linked parkinsonism. Proc. Natl. Acad. Sci. U.S.A. 105, 2693&#8211;2698.               10.1016/j.yexcr.2008.02.015 <br />    doi: 10.1073/pnas.0708452105                                                             Simon-Sanchez, J., Herranz-Perez, V., Olucha-Bordonau, F., Perez-Tur, J. <br /> Macleod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., Abe-                          (2006). LRRK2 expressed areas affected Parkinson&#8217;s disease adult <br />    liovich, A. (2006). The familial parkinsonism gene LRRK2 regulates neu-                    mouse brain. Eur. J. Neurosci. 23, 659&#8211;666. doi: 10.1111/j.1460-9568.2006. <br />    rite process morphology. Neuron 52, 587&#8211;593. doi: 10.1016/j.neuron.2006.                   04616.x <br />    10.008                                                                                   Skibinski, G., Nakamura, K., Cookson, M. R., Finkbeiner, S. (2014). <br /> Marin, I. (2008). Ancient origin Parkinson disease gene LRRK2. J. Mol. Evol.           Mutant LRRK2 toxicity neurons depends LRRK2 levels synuclein <br />    67, 41&#8211;50. doi: 10.1007/s00239-008-9122-4                                                  kinase activity inclusion bodies. J. Neurosci. 34, 418&#8211;433. doi: <br /> Martin, I., Kim, J. W., Lee, B. D., Kang, H. C., Xu, J. C., Jia, H., et al.                   10.1523/JNEUROSCI.2712-13.2014 <br />    (2014). Ribosomal protein s15 phosphorylation mediates LRRK2 neurode-                    Smith, W. W., Pei, Z., Jiang, H., Moore, D. J., Liang, Y., West, A. B., et al. (2005). <br />    generation Parkinson&#8217;s disease. Cell 157, 472&#8211;485. doi: 10.1016/j.cell.2014.            Leucine-rich repeat kinase 2 (LRRK2) interacts parkin mutant LRRK2 <br />    01.064                                                                                     induces neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 102, 18676&#8211;18681. <br /> Matta, S., Van Kolen, K., da Cunha, R., van den Bogaart, G., Mandemakers, W.,                 doi: 10.1073/pnas.0508052102 <br />    Miskiewicz, K., et al. (2012). LRRK2 controls EndoA phosphorylation cycle          Stafa, K., Trancikova, A., Webber, P. J., Glauser, L., West, A. B., Moore, <br />    synaptic endocytosis. Neuron 75, 1008&#8211;1021. doi: 10.1016/j.neuron.2012.08.022              D. J. (2012). GTPase activity neuronal toxicity Parkinson&#8217;s disease- <br /> Mazzulli, J. R., Xu, Y. H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G.               associated LRRK2 regulated ArfGAP1. PLoS Genet. 8:e1002526. doi: <br />    A., et al. (2011). Gaucher disease glucocerebrosidase alpha-synuclein form             10.1371/journal.pgen.1002526 <br />    bidirectional pathogenic loop synucleinopathies. Cell 146, 37&#8211;52. doi:              Taylor, J. P., Mata, I. F., Farrer, M. J. (2006). LRRK2: common pathway for <br />    10.1016/j.cell.2011.06.001                                                                 parkinsonism, pathogenesis prevention? Trends Mol. Med. 12, 76&#8211;82. doi: <br /> Muda, K., Bertinetti, D., Gesellchen, F., Hermann, J. S., von Zweydorf, F., Geerlof,          10.1016/j.molmed.2005.12.004 <br />    A., et al. (2014). LRRK2 mutation R1441C/G/H impairs PKA phosphorylation              Tong, Y., Yamaguchi, H., Giaime, E., Boyle, S., Kopan, R., Kelleher, R. J. III, et al. <br />    LRRK2 disrupts interaction 14-3-3. Proc. Natl. Acad. Sci. U.S.A. 111,         (2010). Loss leucine-rich repeat kinase 2 causes impairment protein degra- <br />    E34&#8211;E43. doi: 10.1073/pnas.1312701111                                                      dation pathways, accumulation alpha-synuclein, apoptotic cell death in <br /> Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D. F., Gautier, C. A., Shen,                   aged mice. Proc. Natl. Acad. Sci. U.S.A. 107, 9879&#8211;9884. doi: 10.1073/pnas. <br />    J., et al. (2010). PINK1 selectively stabilized impaired mitochon-                   1004676107 <br />    dria activate Parkin. PLoS Biol. 8:e1000298. doi: 10.1371/journal.pbio.               Usenovic, M., Knight, A. L., Ray, A., Wong, V., Brown, K. R., Caldwell, G. <br />    1000298                                                                                    A., et al. (2012). Identi&#65533;?cation novel ATP13A2 interactors role in <br /> Nichols, R. J., Dzamko, N., Morrice, N. A., Campbell, D. G., Deak, M., Ordureau,              alpha-synuclein misfolding toxicity. Hum. Mol. Genet. 21, 3785&#8211;3794. doi: <br />    A., et al. (2010). 14-3-3 binding LRRK2 disrupted multiple Parkinson&#8217;s            10.1093/hmg/dds206 <br />    disease-associated mutations regulates cytoplasmic localization. Biochem. J.         Varkey, J., Isas, J. M., Mizuno, N., Jensen, M. B., <span id='am-42' about='obo:NCBITaxon_706860' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_30102 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_35567 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_7524 obo:NCBITaxon_6960 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_33372 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33365 obo:NCBITaxon_33342 obo:NCBITaxon_33368 obo:NCBITaxon_50557'><span id='am-43' property="rdfs:label" content="Bhatia" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-45'  ></span><span id='am-46' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Bhatia</span>, V. K., Jao, C. C., <br />    430, 393&#8211;404. doi: 10.1042/BJ20100483                                                      et al. (2010). Membrane curvature induction tubulation common fea- <br /> Pankratz, N., Wilk, J. B., Latourelle, J. C., DeStefano, A. L., Halter, C., Pugh, E. W.,      tures synucleins apolipoproteins. J. Biol. Chem. 285, 32486&#8211;32493. doi: <br />    et al. (2009). Molecular genetic, genomewide association study susceptibility          10.1074/jbc.M110.139576 <br />    genes contributing familial Parkinson disease. Hum. Genet. 124, 593&#8211;605. doi:         Venderova, K., Kabbach, G., Abdel-Messih, E., Zhang, Y., Parks, R. J., Imai, Y., et al. <br />    10.1007/s00439-008-0582-9                                                                  (2009). Leucine-rich repeat kinase 2 interacts Parkin, DJ-1 PINK-1 in <br />  <br />  <br />  <br />  <br /> Frontiers Molecular Neuroscience                                           www.frontiersin.org                                           July 2014 | Volume 7 | Article 64 | 7 <br />  Boon et al.                                                                                                                            LRRK2 regulator cellular signaling <br />  <br />  <br />  <br />  <br />   <span id='am-22' about='obo:NCBITaxon_7227' typeof='owl:Thing obo:NCBITaxon_7214 obo:NCBITaxon_32351 obo:NCBITaxon_33340 obo:NCBITaxon_7215 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_186285 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_46879 obo:NCBITaxon_43738 obo:NCBITaxon_43845 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_46877 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_32341 obo:NCBITaxon_33208 obo:NCBITaxon_32346 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_43746 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-23' property="oboInOwl:hasRelatedSynonym" content="Drosophila melangaster" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-26' property="rdfs:label" content="Drosophila melanogaster" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasExactSynonym" content="fruit fly" datatype="xsd:string"></span><span id='am-28'  ></span>Drosophila melanogaster</span> model Parkinson&#8217;s disease. Hum. Mol. Genet. 18,            Yao, C., El Khoury, R., Wang, W., Byrd, T. A., Pehek, E. A., <br />   4390&#8211;4404. doi: 10.1093/hmg/ddp394                                                        Thacker, C., et al. (2010). LRRK2-mediated neurodegeneration dys- <br /> Verhey, K. J., Meyer, D., Deehan, R., Blenis, J., Schnapp, B. J., Rapoport, T. A.,          function dopaminergic neurons Caenorhabditis elegans model of <br />   et al. (2001). Cargo kinesin identi&#65533;?ed JIP scaffolding proteins asso-       <br /> </body></html>